- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04190264
Body Cooling in Hyperthermic Males and Females
April 7, 2020 updated by: William Adams, University of North Carolina, Greensboro
Efficacy of the Polar Breeze Thermal Rehabilitation Machine in Cooling Recreationally Active Males and Females Following Exercise-induced Hyperthermia
Exertional heat stroke (EHS) is an emergency medical condition that is prevalent in military soldiers, athletes, and laborers.
It is diagnosed when the rectal temperature is above 40°C with the presence of central nervous dysfunction (altered mental status).
The gold standard method of care for EHS is immediate onsite whole body cooling using cold-water immersion (cooling rates >0.15°C•min-1), which is reported to have the highest cooling rate.
In the treatment of EHS, selecting a cooling modality with a high cooling rate becomes crucial to minimize the time above the critical threshold of body temperature at 40°C to less than 30 minutes for the best chance of survival and to minimize the severity of prognosis.
However, in situations where cold water immersion is not feasible (in certain military, firefighter, or other remote settings), other cooling modalities must be available that have a cooling capacity similar to that of cold-water immersion.
In this proposed study, we aim to compare the cooling rates of the Polar Breeze® (developed by Polar Breeze ®, Clearwater, FL), cold-water immersion (the current gold standard for EHS treatment), and passive cooling in individuals with exercise-induced hyperthermia
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27412
- University of North Carolina at Greensboro
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- males and females between the ages of 18-35.
- recreationally active (regularly exercise at a minimum of 4-5 times per week for greater than 30 minutes per session)
Exclusion Criteria:
- chronic health problems
- fever or current illness at the time of testing
- history of cardiovascular, metabolic, or respiratory disease
- current musculoskeletal injury that limits physical activity
- history of exertional heat illness in the past three years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Thermal rehab machine
Participants, following exercise-induced hyperthermia, will be cooled using a Thermal Rehab Machine (Polar Breeze, Statim Technologies, LLC, Clearwater Florida), which is a micro-environmental air chiller.
The device will be placed over the subjects head and through trans pulmonary cooling, will cool the body.
|
The Polar Breeze unit is a microenvironmental air-chiller.
That means it is a single-pass air-conditioner capable of cooling external air
Other Names:
|
No Intervention: Passive Cooling
Participants, following exercise-induced hyperthermia, will undergo a period of passive rest to allow the body to cool via natural mechanisms of evaporation of sweat from the skin's surface and convection
|
|
Active Comparator: Cold Water Immersion
Participants, following exercise-induced hyperthermia, will be cooled using cold water immersion.
Participants will be immersed up to their chest in cold water (~50-55 Degrees Fahrenheit).
|
Whole-body immersion in cold water.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Internal Body Temperature
Time Frame: 0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60 minutes post onset of cooling
|
The rate at which body temperature is reduced during whole body cooling following exercise-induced hyperthermia.
|
0, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60 minutes post onset of cooling
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2019
Primary Completion (Actual)
March 31, 2020
Study Completion (Actual)
March 31, 2020
Study Registration Dates
First Submitted
December 3, 2019
First Submitted That Met QC Criteria
December 4, 2019
First Posted (Actual)
December 9, 2019
Study Record Updates
Last Update Posted (Actual)
April 8, 2020
Last Update Submitted That Met QC Criteria
April 7, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- A20-0085
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cryotherapy Effect
-
North Dakota State UniversityCompletedCryotherapy EffectUnited States
-
University of Applied Sciences and Arts of Southern...Completed
-
Asir John SamuelCompletedCryotherapy Effect | Balance; Disorder, FluidIndia
-
Wonik Trade Company, KoreaCompletedCryotherapy Effect | LipolysisKorea, Republic of
-
Istanbul Physical Medicine Rehabilitation Training...Completed
-
Versailles HospitalCompletedCryotherapy EffectFrance
-
Hanyang University Seoul HospitalCompletedCryotherapy EffectKorea, Republic of
-
Institut de Formation en Masso-Kinésithérapie Saint...CompletedKnee Arthropathy | Cryotherapy EffectFrance
-
Universidade Federal de Santa MariaCompletedInflammatory Response | Muscle, Skeletal | Massage | Cryotherapy Effect | Functional DisturbanceBrazil
-
Centre Hospitalier Universitaire de BesanconCompletedCryotherapy Effect | Arthritis Knee
Clinical Trials on Thermal Rehabilitation Machine
-
University of North Carolina, GreensboroStatim Technologies, LLCCompletedCryotherapy EffectUnited States
-
Taipei Veterans General Hospital, TaiwanUnknownFrailty Syndrome | Intelligent POWER Rehabilitation Cluster MachineTaiwan
-
The University of Texas Health Science Center,...National Institute of Neurological Disorders and Stroke (NINDS); University... and other collaboratorsCompletedStroke | HemiparesisUnited States
-
University of HoustonThe University of Texas Health Science Center, Houston; TIRR Memorial HermannRecruitingStroke | HemiparesisUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompletedBypass Graft StenosisFrance
-
Chinese PLA General HospitalWithdrawn
-
University Hospital TuebingenMax-Planck-Institute TuebingenUnknown
-
Mayo ClinicWithdrawnOsteoarthritis | Inflammatory ArthritisUnited States
-
University of ChicagoNational Cancer Institute (NCI)WithdrawnStage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | Invasive Ductal Breast CarcinomaUnited States
-
Chattem, Inc.TerminatedHealthyUnited States